Entity Details

Primary name MAF_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO75444
EntryNameMAF_HUMAN
FullNameTranscription factor Maf
TaxID9606
Evidenceevidence at protein level
Length373
SequenceStatuscomplete
DateCreated2002-07-11
DateModified2021-06-02

Ontological Relatives

GenesMAF

GO terms

Show/Hide Table
GOName
GO:0000122 negative regulation of transcription by RNA polymerase II
GO:0000785 chromatin
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0006357 regulation of transcription by RNA polymerase II
GO:0006366 transcription by RNA polymerase II
GO:0010628 positive regulation of gene expression
GO:0032330 regulation of chondrocyte differentiation
GO:0048468 cell development
GO:0048839 inner ear development
GO:0070306 lens fiber cell differentiation
GO:1990837 sequence-specific double-stranded DNA binding

Subcellular Location

Show/Hide Table
Subcellular Location
Nucleus

Domains

Show/Hide Table
DomainNameCategoryType
IPR004826 Basic leucine zipper domain, Maf-typeDomainDomain
IPR004827 Basic-leucine zipper domainDomainDomain
IPR008917 Transcription factor, Skn-1-like, DNA-binding domain superfamilyFamilyHomologous superfamily
IPR013592 Maf transcription factor, N-terminalDomainDomain
IPR024874 Transcription factor Maf familyFamilyFamily
IPR028573 Transcription factor MafFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
601088 OMIMAyme-Gripp syndrome (AYGRP)A multisystem disorder characterized by congenital cataracts, sensorineural deafness, intellectual disability, seizures, brachycephaly, distinctive flat facial appearance, skeletal anomalies, mammary gland hypoplasia, and reduced growth. The disease is caused by variants affecting the gene represented in this entry.
610202 OMIMCataract 21, multiple types (CTRCT21)An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT21 includes cerulean and pulverulent cataracts. Cerulean cataracts are characterized by peripheral bluish and white opacifications organized in concentric layers with occasional central lesions arranged radially. The opacities are observed in the superficial layers of the fetal nucleus as well as the adult nucleus of the lens. Involvement is usually bilateral. Visual acuity is only mildly reduced in childhood. In adulthood, the opacifications may progress, making lens extraction necessary. Histologically the lesions are described as fusiform cavities between lens fibers which contain a deeply staining granular material. Although the lesions may take on various colors, a dull blue is the most common appearance and is responsible for the designation cerulean cataract. Pulverulent cataracts are characterized by a dust-like, 'pulverised' appearance of the opacities which can be found in any part of the lens. In some cases cataract is associated with microcornea without any other systemic anomaly or dysmorphism. Microcornea is defined by a corneal diameter inferior to 10 mm in both meridians in an otherwise normal eye. The disease is caused by variants affecting the gene represented in this entry.

Interactions

30 interactions

InteractorPartnerSourcesPublicationsLink
MAF_HUMANBACH1_HUMANHPIDb20102225 details
MAF_HUMANMAFB_HUMANBioGRID, HPIDb, UniProt20102225 23661758 details
MAF_HUMANATF4_HUMANBioGRID, HPIDb, UniProt20102225 23661758 details
MAF_HUMANMAF_HUMANBioGRID, HPIDb, HPRD, UniProt12011435 12149651 20102225 23661758 details
MAF_HUMANJUNB_HUMANUniProt23661758 details
MAF_HUMANFOSL1_HUMANBioGRID, UniProt23661758 details
MAF_HUMANEP300_HUMANBioGRID, HPRD11943779 details
MAF_HUMANUSF2_HUMANBioGRID, HPRD9070273 details
MAF_HUMANSOX9_HUMANBioGRID, HPRD12381733 details
MAF_HUMANMYB_HUMANBioGRID, HPRD9566892 details
MAF_HUMANETS1_HUMANBioGRID, HPRD9566892 details
MAF_HUMANMAFG_HUMANBioGRID, HPRD12149651 details
MAF_HUMANHXD12_HUMANBioGRID11036080 details
MAF_HUMANFOS_HUMANBioGRID, HPRD21163924 23661758 8108109 details
MAF_HUMANUBE2O_HUMANBioGRID28673317 32842143 details
MAF_HUMANAHR_HUMANBioGRID, InnateDB20676092 20676095 details
MAF_HUMANCBP_HUMANBioGRID, HPRD11943779 details
MAF_HUMANKDM5B_HUMANBioGRID19336002 details
MAF_HUMANCEBPA_HUMANBioGRID17082780 details
MAF_HUMANSMCA5_HUMANBioGRID, HPRD16675956 details
MAF_HUMANHDAC2_HUMANBioGRID17287852 details
MAF_HUMANSIN3A_HUMANBioGRID17287852 details
MAF_HUMANUBC9_HUMANBioGRID19553542 details
MAF_HUMANPML_HUMANBioGRID19553542 details
MAF_HUMANNF2L2_HUMANBioGRID26078718 details
MAF_HUMANUBP5_HUMANBioGRID28933784 31197245 32842143 details
MAF_HUMANUBP7_HUMANBioGRID31822558 details
MAF_HUMANOTUB1_HUMANBioGRID32842143 details
MAF_HUMANJUN_HUMANHPRD8108109 details
MAF_HUMANMAFA_HUMANHPRD12011435 details